BRIEF published on 08/19/2026 at 16:00, 2 months 13 days ago Storm Exploration Secures Drill Permit for Gold Standard Project Gold Standard Project Northwestern Ontario Exploration Permit Semi-annual Reporting VMS Target
BRIEF published on 08/19/2026 at 16:00, 2 months 13 days ago Storm Exploration obtient un permis de forage pour un projet de référence aurifère Permis D'exploration Projet De Référence Rapport Semestriel Nord-Ouest De L'Ontario Cible VMS
BRIEF published on 08/19/2026 at 15:50, 2 months 13 days ago Valneva SE's Q2 Sales Decline Amid New Projections Valneva SE Q2 Sales Decline Ixiaro Contract Gross Margin Rebound LB6V Vaccine Approval
BRIEF published on 08/19/2026 at 15:50, 2 months 13 days ago Les ventes de Valneva SE au deuxième trimestre sont en baisse malgré de nouvelles prévisions. Valneva SE Baisse Des Ventes Au Deuxième Trimestre Contrat Ixiaro Rebond De La Marge Brute Approbation Du Vaccin LB6V
BRIEF published on 08/19/2026 at 15:44, 2 months 13 days ago Hapag-Lloyd Acquires 25% Stake in APM Terminals Maasvlakte II Expansion Investment Hapag-Lloyd APM Terminals Maasvlakte II
BRIEF published on 08/19/2026 at 15:44, 2 months 13 days ago Hapag-Lloyd acquiert une participation de 25 % dans APM Terminals Maasvlakte II Investissement Expansion Hapag-Lloyd Maasvlakte II Terminaux APM
BRIEF published on 08/19/2026 at 14:55, 2 months 13 days ago Wolford AG Reports Improved EBIT Despite Stable Revenue Market Challenges Wolford AG Revenue Stability EBIT Improvement Transformation Progress
BRIEF published on 08/19/2026 at 14:55, 2 months 13 days ago Wolford AG annonce une amélioration de son EBIT malgré un chiffre d'affaires stable Wolford AG Défis Du Marché Stabilité Des Revenus Amélioration De L'EBIT Progrès De La Transformation
BRIEF published on 08/19/2026 at 14:45, 2 months 13 days ago Revive Therapeutics Advances Biodefence Strategy with Bucillamine Medical Countermeasures Pandemic Preparedness Government Partnerships Bucillamine Biodefence
BRIEF published on 08/19/2026 at 14:45, 2 months 13 days ago Revive Therapeutics fait progresser sa stratégie de biodéfense avec la bucillamine Biodefense Contre-mesures Médicales Préparation Aux Pandémies Bucillamine Partenariats Gouvernementaux
Published on 10/30/2026 at 23:35, 2 days 2 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 3 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 7 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 11 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 15 hours 58 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 21 hours 33 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 9 hours ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 2 days 3 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 2 days 3 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 2 days 3 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
